Company: GEHC
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001628280-25-017240
Chunk: 1

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 1
---
 No. 3: Ratification of the Appointment of Deloitte & Touche LLP as Our Independent Auditor for the Fiscal Year Ending December31, 2025 |     |                                                    |
| 74 |     |                                                                                                                                      Review and Engagement |     |                                                    |
| 75 |     |                                                                                                                                     Audit Committee Report |     |                                                    |
| 76 |     |                                                                                                                            Fees Paid to IndependentAuditor |     |                                                    |
| 77 |     |                                                                                                                                       Stockholder Proposal |     |                                                    |
| 79 |     |                                                                                                                                   Submitting 2026Proposals |     |                                                    |
| 80 |     |                                                                                                                             Voting and Meeting Information |     |                                                    |
| 83 |     |                                                                                                                                                   Appendix |     |                                                    |
| 83 |     |                                                                                                                                Non-GAAP Financial Measures |     |                                                    |

#### Forward-Looking Statements
This proxy statement contains forward-looking statements. These forward-looking statements might be identified by words, and variations of words, such as “will,” “expect,” “may,” “would,” “could,” “plan,” “believe,” “anticipate,” “intend,” “estimate,” “potential,” “position,” “forecast,” “target,” “guidance,” “outlook,” and similar expressions. These forward-looking statements may include, but are not limited to, statements about our business operations; our strategy; governance, sustainability, and compensation practices and policies; our agreements with General Electric Company (“GE”); and financial information. Please see our risk factors, as they may be amended from time to time, set forth in our filings with the U.S. Securities and Exchange Commission (the “SEC”), including our most recently filed Annual Report on Form 10-K (the “2024 Form 10-K”). There may be other factors not presently known to us or which we currently consider to be immaterial that could cause our actual results to differ materially from those projected in any forward-looking statements we make. We do not undertake any obligation to update or revise our forward-looking statements except as required by applicable law or regulation.

#### 2GE HEALTHCARE 2025 PROXY STATEMENT

#### Proxy Statement Summary
This section summarizes and highlights certain information contained in this proxy statement but does not contain all the information that you should consider when casting your vote. Please review the entire proxy statement as well as the 2024 Form 10-K carefully before voting.

#### 2025 Annual Meeting of Stockholders
Date and Time: